Who owns LIXTE BIOTECHNOLOGY HOLDINGS?
- CUSIP Number: 539319301
Tip: Access positions for across all investors
Analyze quarterly positions in Lixte Biotechnology Holdings with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Lixte Biotechnology Holdings stock
Who bought or sold LIXTE BIOTECHNOLOGY HOLDINGS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Legacy Wealth Managment | 601k | $4.5M | 100% | Jun 2026 |
|
| Vanguard Capital Management | 556k | $4.1M | 1023% | Jun 2026 |
|
| Scotia Capital | 283k | $2.1M | 0% | Jun 2026 |
|
| Geode Capital Management | 143k | $1.1M | 143% | Jun 2026 |
|
| BlackRock | 76k | $564k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 67k | $499k | 92% | Jun 2026 |
|
| FNY Investment Advisers | 45k | $330k | 100% | Jun 2026 |
|
| Federation des caisses Desjardins du Quebec | 38k | $283k | -41% | Jun 2026 |
|
| Northern Trust | 28k | $205k | 100% | Jun 2026 |
|
| Ethos Financial Group | 25k | $100k | 0% | Jun 2026 |
|
| State Street Corporation | 17k | $53k | 0% | Mar 2026 |
|
| Axxcess Wealth Management | 14k | $102k | 100% | Jun 2026 |
|
| Atlas Legacy Advisors | 14k | $102k | 0% | Jun 2026 |
|
| Equitable Holdings | 10k | $74k | 100% | Jun 2026 |
|
| UBS Group | 6.4k | $48k | 100% | Jun 2026 |
|
| SBI Securities | 190.00 | $1.4k | 0% | Jun 2026 |
|
| Caitong International Asset Management | 7.00 | $52.000200 | 100% | Jun 2026 |
|
| Wells Fargo & Company | 5.00 | $37.000000 | 100% | Jun 2026 |
|
Who sold out of Lixte Biotechnology Holdings?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Mar 2026 | 93k | $286k |
| Citadel Advisors | Mar 2026 | 57k | $174k |
| XTX Topco | Mar 2026 | 23k | $72k |
| Hrt Financial | Mar 2026 | 11k | $34k |
| Tower Research Capital | Mar 2026 | 973.00 | $3.0k |